VF
CMPX icon

Virtu Financial’s Compass Therapeutics CMPX Stock Holding History

Virtu Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
+43,066
New +$249K 0.01% 956
2025
Q4 		– Sell
-12,681
Closed -$44K – 1749
2025
Q3 		$44K Buy
+12,681
New +$40.1K ﹤0.01% 1151
2024
Q3 		– Sell
-51,233
Closed -$51K – 1448
2024
Q2 		$51K Buy
+51,233
New +$74.8K ﹤0.01% 900
2024
Q1 		– Sell
-28,054
Closed -$44K – 1500
2023
Q4 		$44K Buy
+28,054
New +$48.5K ﹤0.01% 1193

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Virtu Financial's CMPX Position: Q1 2026 in Review

Virtu Financial opened a new position in Compass Therapeutics (CMPX) in Q1 2026: 43,066 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #956 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CMPX as recently as Q3 2025.

Virtu Financial first reported a position in CMPX in Q4 2023 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Virtu Financial held 43,066 shares of Compass Therapeutics worth $228K as of Q1 2026.
  • Compass Therapeutics was a new Virtu Financial position in Q1 2026.
  • Compass Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #956 holding.
  • Virtu Financial first reported a position in Compass Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.